ProShares - UltraShort Nasdaq Biotechnology (BIS) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
ProShares - UltraShort Nasdaq Biotechnology (BIS) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $2.4M, listed on NASDAQ, carrying a beta of -1.20 to the broader market. ProShares UltraShort Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index. public since 2010-04-09.
Snapshot as of May 15, 2026.
- Spot Price
- $8.76
- Total OI
- 13